Real-Time Testing for Helicobacter Pylori and Atrophy of the Gastric Body: Reply to the Editorial of D. Graham

In an editorial in the October issue of Endoscopy [1] accompanying our study on a novel device for testing for Helicobacter pylori and gastric atrophy, namely the Mt 21 - 42 [2], Graham suggested that it was a tool that endoscopists would only have needed several decades ago and whose clinical usefulness had probably passed. We think that the arguments he uses to support that conclusion are highly debatable and want to clarify the issue from our standpoint. In answer to his editorial, we have to consider three points:

References

• 1 Graham D Y. Is real-time testing for Helicobacter pylori and corpus atrophy clinically useful in 2005?.  Endoscopy. 2005;  37 1006-1007
• 2 Tucci A, Tucci P, Bisceglia M. et al . Real-time detection of Helicobacter pylori infection and atrophic gastritis: comparison between conventional methods and a novel device for gastric juice analysis during endoscopy.  Endoscopy. 2005;  37 966-976
• 3 Belair P A, Metz D C, Faigel D O, Furth E E. Receiver operator characteristic analysis of endoscopy as a test for gastritis.  Dig Dis Sci. 1997;  42 2227-2233
• 4 Carpenter H A, Talley N J. Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis.  Gastroenterology. 1995;  108 917-924
• 5 Toth E, Sjolund K, Fork F T, Lindstrom C. Chronic atrophic fundic gastritis diagnosed by a modified Congo red test.  Endoscopy.. 1995;  27 654-658
• 6 Ricci C, Vakil N, Rugge M. et al . Serological markers for atrophic gastritis in asymptomatic patients infected with Helicobacter pylori.  Am J Gastroenterol. 2004;  99 1-6
• 7 Vaananen H, Vauhkonen M, Helske T. et al . Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.  Eur J Gastroenterol Hepatol. 2003;  15 885-891
• 8 Lindgren A, Lindgren A, Lindstedt G. Advantages of serum pepsinogen A combined with gastrin or pepsinogen C as first-line analytes in the evaluation of suspected cobalamin deficiency: a study in patients previously not subjected to gastrointestinal surgery.  J Int Med. 1998;  244 341-349
• 9 Sanduleanu S, Bruine A D, Biemond I. et al . Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis.  Eur J Clin Invest. 2003;  33 147-154
• 10 Furuta T, ElOmar E M, Xiao F. et al . Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.  Gastroenterology. 2002;  123 92-105
• 11 Annibale B, Capurso G, Lahner E. et al . Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia.  Gut. 2003;  52 496-501
• 12 Farinati F, Cardin F, Di Mario F. et al . Perendoscopic gastric pH determination. Simple method for increasing accuracy in diagnosing chronic atrophic gastritis.  Gastrointest Endosc. 1987;  33 293-297
• 13 Jaskiewicz K, Van Helden P D, Wiid I J. et al . Chronic atrophic gastritis, gastric pH, nitrites and micronutrient levels in a population at risk for gastric carcinoma.  Anticancer Res. 1990;  10 833-836
• 14 Andersen J, Strom M. A technique for screening of achlorhydria and hypochlorhydria during upper gastrointestinal endoscopy.  Scand J Gastroenterol. 1990;  25 1084-1088
• 15 Segawa K, Nakazawa S, Tsukamoto Y. et al . Estimate of gastric acid output by evaluation of fasting gastric juice collected endoscopically.  Hepatogastroenterology. 1991;  38 (Suppl 1) 9-82
• 16 Kamada T, Hata J, Sugiu K. et al . Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan.  Aliment Pharmacol Ther. 2005;  21 1121-1126
• 17 Uemura N, Okamoto S, Yamamoto S. et al . Helicobacter pylori infection and the development of gastric cancer.  N Engl J Med. 2001;  345 829-832
• 18 Ohata H, Kitauchi S, Yoshimura N. et al . Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer.  Int J Cancer. 2004;  109 138-143
• 19 Annibale B, Azzoni C, Corleto V D. et al . Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid.  Eur J Hepatol Gastroenterol. 2001;  13 1449-1456
• 20 Bordi C. Endocrine tumours of the stomach.  Pathol Res Pract. 1995;  191 373-380
• 21 Lahner E, Caruana P, D’Ambra G. et al . First endoscopic-histologic follow-up in patients with body-predominant atrophic gastritis: when should it be done?.  Gastrointest Endosc. 2001;  53 443-448
• 22 Malfertheiner P, Megraud F, O’Morain C. et al . Current concepts in the management of Helicobacter pylori infection - the Maastricht 2 - 2000 Consensus Report.  Aliment Pharmacol Ther. 2002;  16 167-180
• 23 Satoh K. Indications for Helicobacter pylori eradication therapy and first-line therapy regimen in Japan: recommendation by the Japanese Society for Helicobacter Research.  J Gastroenterol. 2002;  37 (Suppl 13) 34-38